The federal Project Grant award R01DK140129, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to optimize the allocation of kidneys from deceased African American donors with APOL1 high-risk genotypes. The primary goal is to identify clinically actionable approaches to determine which of these kidneys are truly "high risk" for...
This Project Grant award in the amount of $2,202,378.00 was awarded on September 20, 2024 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research to investigate the protective role of the transcription factor KLF2 in diabetic kidney disease (DKD) and its potential as a drug target. The key objectives are to determine how KLF2 is regulated in diabetic...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $214,958 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The Washington University in St. Louis to investigate the role of Interferon-Stimulated Gene 15 (ISG15) as a regulator of cell death during acute kidney injury (AKI). The research aims to advance the understanding of cell death pathways involved in AKI, a common and serious clinical condition,...
The federal Project Grant award R01DK140070, in the amount of $700,619, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research (CFDA 93.847) program. The goal of this 4-year award is to study and control rhythmic nephron induction for kidney replacement tissues. The research aims to gain temporal control over rhythmic nephron formation in human induced pluripotent stem cell-derived kidney...
This $820,119 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research focused on elucidating the mechanobiological functions of novel cytoskeletal structures in podocytes to reveal new therapeutic opportunities for kidney glomerular diseases. The primary research aims to better understand the mechanisms underlying podocyte homeostasis,...
This federal Project Grant award for $892,433.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research aimed at understanding the role of eicosanoids (bioactive lipid molecules) in the development of chronic kidney disease (CKD) and associated cardiovascular risk. The research project, led by the principal investigator at Cedars-Sinai Medical Center,...
This federal Project Grant award of $344,632 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research to evaluate the impact of recent changes to the kidney allocation system in the United States. The research aims to: (1) assess whether the supply of organs is equitably distributed among U.S. transplant centers under the new 250-nautical-mile kidney...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to develop an AI-assisted system for interpreting kidney biopsy images to reduce inappropriate organ discards. The $1,470,094 award to New York University School of Medicine aims to: (1) construct a comprehensive atlas of kidney biopsy histopathology using...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on investigating the mechanisms of renal lipotoxicity and its contribution to chronic kidney disease (CKD). The total funding amount is $128,286.00, with an award date of December 16, 2024 and an ultimate completion date of June 30, 2027. The primary goals of the research are to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research focused on understanding the molecular and genetic mechanisms underlying ischemic acute kidney injury (AKI). The $117,000 award, with a performance period from August 2024 to July 2026, will investigate the hypothesis that the transcription factor PAX8 controls sensitivity to...